DTX3 and colorectal carcinoma: Here, our results demonstrated that DTX3 KO significantly elevated, while the addition of PD 0332991, an inhibitor of E2F1 transcription, inhibited the expression of both CDC2 and Cyclin D3 in CRC cells.